The largest database of trusted experimental protocols

202 protocols using stain buffer

1

Leukocyte Processing and Staining Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
For each sample, 20 × 106 leukocytes were processed as already described7 (link) within 4 hours from material collection. In details, the sample volume containing 20 × 106 leukocytes underwent an erythrocyte-lysis step, with 45 mL of Pharm Lyse solution (BD Biosciences) for 15 minutes at RT, under gentle agitation. Samples were then centrifuged (400 g, 10 min, room temperature) and washed by adding 2 mL of Stain Buffer (BD Biosciences). The pellet of each sample was added to the lyophilized cocktail of reagents, previously re-hydrated by the addition of 100 µl of Stain Buffer (BD Biosciences); 1 µM Syto16 (Thermo Fisher Scientific, Eisai, Medipost - US) was finally added, as liquid drop-in, to each tube. Samples were incubated in the dark for 30 minutes at 4 °C, washed with 2 mL of Stain Buffer (BD Biosciences), centrifuged (400 g, 10 min, room temperature), and re-suspended in 1.5 mL of FACSFlow (BD Biosciences).
+ Open protocol
+ Expand
2

Flow Cytometry Immunophenotyping Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
The cells were detached with Accutase Cell Detachment Solution (BD), washed in PBS, and resuspended in Stain Buffer (BD). Flow cytometry analyses were performed with antibodies listed in Table 1. The cells were incubated in diluted antibodies in the dark for 30 min. After incubation, the cells were washed twice with Stain Buffer (BD) and resuspended in Stain Buffer. The resuspended cells were analyzed using FACS Canto II (BD) with FACSDiva software (BD) and FlowJo 10 (BD). The following laser configurations were applied: violet - 407 nm (detectors: 510/50, 450/50), blue - 488 nm (detectors: 488,10, 530/30, 585/42, 670LP, 780/60), and red - 633 nm (detectors: 660/20, 780/60). The gating strategy was presented in online resources (Supplementary Figure S2).
+ Open protocol
+ Expand
3

Characterizing Human Corneal Endothelial Cell Phenotype

Check if the same lab product or an alternative is used in the 5 most similar protocols
HCECs were grown to confluence in selected proliferation media and cultured for 12 days in corresponding maturation media prior to flow cytometry analysis. All HCECs in each treatment were trypsinized, washed in BD stain buffer for 5 min (BD Biosciences, Franklin Lakes, NJ), and centrifuged at 300xg for 5 minutes. Cells were incubated with fluorescent-conjugated antibodies against CD56, CD73, and CD166 (BD Biosciences) at 4°C for 20 minutes in a container to limit light exposure. Labelled cells were washed three times for 5 min each in BD stain buffer, incubated with 1% formalin (Fisher, Waltham, MA) in BD stain buffer, and analyzed on a BD FACSCanto flow cytometer, collecting data from at least 20,000 cells per treatment. Mean fluorescent intensity (MFI) of live-gated cells was calculated for each marker and compared to other markers to produce a ratio.
+ Open protocol
+ Expand
4

Multiparametric Flow Cytometry of Cardiac Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Single-cell suspensions obtained at the indicated times of cardiac differentiation were resuspended in BD Stain Buffer (BD Biosciences) and stained with different combinations of antibodies against cell-surface markers (antibodies are detailed in Table S3). Cells were stained for 20 min at RT in the dark. For the detection of intracellular cTNI, cells were fixed and permeabilized after the surface marker stain using a BD Cytofix/Cytoperm Solution Kit (BD Biosciences). In brief, cells were incubated with fixation/permeabilization solution for 20 min at RT, then washed twice with BD Perm/Wash Buffer and incubated with AlexaFluor anti-cTNI antibody for 20 min at RT in the dark. Following antibody staining, cells were washed with, and resuspended in, BD Stain Buffer and analyzed on a BD LSRFortessa (BD Biosciences). Parental H9 cells and isotype controls were used to define the cytometric gates.
+ Open protocol
+ Expand
5

Multiparametric Analysis of Monocyte Subsets by FACS

Check if the same lab product or an alternative is used in the 5 most similar protocols
To perform the multiparametric analysis of monocytes by fluorescence-activated cell sorting (FACS), the following antibodies were used: CD14 (FITC), CD16 (PerCP-Cy), CD45 (V500), CD274 (PE-Cy7), and HLA-DR (PE), all purchased from Becton, Dickinson and Co. The PBMCs were incubated with stain buffer (BD) with the respective mix of antibodies for 30 min at 4 °C, protected from light. Cells were washed twice with stain buffer, centrifuged at 300g for 5 min and acquired by the FACSCanto II (Becton, Dickinson and Co.). Raw data were pooled on the FACSDiva platform (Becton, Dickinson and Co.), and fine population analyses were performed in FlowJo V10 software (Tree Star, USA). Compensation controls were performed by CompBeads (BD Biosciences, USA), and the acquisition controls were based on the fluorescence minus one (FMO) method. CD45+ monocytes were stratified as classical monocytes (CD14+CD16), intermediate monocytes (CD14+CD16+), and non-classical monocytes (CD14dimCD16+). See the analysis plan and FMO controls in Supplementary Fig. 1.
+ Open protocol
+ Expand
6

Mesenchymal Stem Cell Surface Marker Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
The expression of specific mesenchymal surface markers was analyzed with Human MSC Analysis Kit (Beckton Dickinson), according to the producers’ protocol. Firstly, ASC and DFAT cells in passage 2 were detached from plates by Accutase Cell Detachment Solution (Beckton Dickinson) and suspended in BD Stain Buffer (Beckton Dickinson). The specific antibodies against CD90, CD73, CD105 (positive markers) and CD34, CD11b, CD19, CD45, and HLA-DR (negative markers) were added, and the cells were incubated in the dark at room temperature (RT) for 30 min. After incubation, the cells were washed, centrifuged, and suspended in Stain Buffer (Beckton Dickinson) and then analyzed by flow cytometry FASC Canto II. The obtained results were analyzed by using FlowJo software version 10.7.1 (Becton Dickinson, New Franklin Lakes, NJ, USA).
+ Open protocol
+ Expand
7

Mesenchymal Stem Cell Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were detached with Accutase Cell Detachment Solution (Beckton Dickinson) and washed in PBS. Required cell number (1 × 106) was resuspend in cold Stain Buffer (Beckton Dickinson) and used for further flow cytometry analysis. Cell markers were analyzed with Human MSC Analysis Kit (Beckton Dickinson) containing antibodies conjugated with fluorochrome against following antigens: CD73, CD90, CD105 (positive markers), CD11b, CD19, CD34, CD45, and PE (negative markers) (Table 1). Cells were incubated in diluted antibodies in the dark for 30 min. After incubation, cells were washed twice with Stain Buffer (Beckton Dickinson) and resuspend in Stain Buffer. Resuspended cells were analyzed using FACS Canto II (Beckton Dickinson) with FACSDiva Software (Beckton Dickinson) and FlowJo 10 (Beckton Dickinson).
In 3rd and 10th div of 3D culture, spheroids were dissociated and resuspended in Stain Buffer. Before running the sample, cells were filtered through 30 µm filter (Miltenyi Biotec, Bergisch Gladbach, Germany) to avoid dublets. Cells were analyzed to compare the change in size with flow cytometry FACS Canto II (Beckton Dickinson) with FACSDiva Software (Beckton Dickinson) and FlowJo 10 (Beckton Dickinson).
+ Open protocol
+ Expand
8

Cell Surface Receptor Expression Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were detached from cell culture dishes, rinsed in PBS, centrifuged, and counted. Cells were washed in BD stain buffer (Becton Dickinson) and resuspended in BD stain buffer with primary antibody (1:250 for ETBR, 1:40 for ETAR, 10 μg/1x105 cells for ECE1) to a concentration of 1x105 cells/100 μl and incubated at room temperature for 45 minutes. Cells were washed twice with BD stain buffer and re-suspended in secondary antibody diluted in BD stain buffer (1:100) and incubated at room temperature for 45 minutes. Cells were washed twice and re-suspended in 200 μl BD stain buffer for flow cytometry analysis. Cells were analyzed on BD Accuri C6 flow cytometer and BD CSampler software (Becton, Dickinson and Company, Franklin Lakes, NJ).
+ Open protocol
+ Expand
9

BCMA Expression in Multiple Myeloma

Check if the same lab product or an alternative is used in the 5 most similar protocols

Example 1

BCMA expression was measured in various cell lines. BCMA was found to be expressed, with a fragments/kilobase of exon/million reads mapped (FPKM) greater than 35, in 99% of multiple myeloma tumor cell lines tested (FIG. 2A). BCMA expression was greater than that of CD70, CS-1, CLL-1, DLL-1 and FLT3 (FIG. 2A). To further characterize the expression of BCMA, EoL-1 (Sigma), NCI-H929 (Molecular Imaging), and MM1S (Molecular Imaging) cells were stained with an anti-BCMA antibody conjugated to PE (Biolegend, San Diego, Calif.) in stain buffer (BD Pharmingen, San Jose, Calif.) for 30 minutes at 4° C. Cells were then washed and resuspended in stain buffer with propidium iodide (BD Pharmingen) prior to data acquisition. Samples were then acquired by flow cytometry and data analyzed (FIGS. 2B-2C). BCMA expression was observed in the myeloma cell lines MMIS (FIG. 2C) and NCI-H929 (FIG. 2D), but not in the human eosinophil cell line EoL-1 (FIG. 2B). In addition, little to no BCMA expression was observed in normal immune cells (FIG. 2E).

+ Open protocol
+ Expand
10

Characterization of Human Bone Marrow-Derived Mesenchymal Stem Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
At passage 3, HBM-MSCs were trypsinized, centrifuged at 300 g for 8 min, and
resuspended in PBS at a concentration of 1 × 106 cells/mL. Next, 100 µL were
incubated for 30 min in 20 µL of antibodies against CD14, CD45 (fluorescein
isothiocyanate [FITC]) or CD73, CD34 phycoerythrin (PE) or in 5 µL of CD105 (PE), or
CD90 (FITC; Becton-Dickinson, Franklin Lakes, NJ, USA); washed with 1 mL of stain buffer
(BD-Pharmingen, San Diego, CA, USA); and resuspended in 500 µL of stain buffer. The
labeled cells were analyzed using an argon ion laser with a wavelength of 488 nm
(FACSCalibur, Becton-Dickinson). A total of 10,000 events was obtained and analyzed with
the Cell Quest software program, Version 5.2.1 (Becton-Dickinson). Control staining with
the appropriate isotype-matched monoclonal antibodies was included.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!